Neogen Chemicals Limited Q2 FY27 Results Set for October 31

Neogen Chemicals Limited will consider its unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026, at a board meeting on October 31. The earnings announcement follows Q1 FY27 revenue of Rs 252.3 crore, up 37% year-on-year in the company’s earnings presentation, as operations recovered despite the Dahej plant disruption.

When will Neogen Chemicals Limited announce Q2 FY27 results?

Neogen Chemicals Limited is scheduled to consider and approve its Q2 FY27 and first-half FY27 financial results at a board meeting on October 31, 2026. The results will cover the quarter and six months ended September 30, 2026, and will include both standalone and consolidated financial statements.

The company had earlier informed exchanges that its trading window would remain closed from October 1 until 48 hours after the declaration of the unaudited results. Such closures are required to restrict trading by designated persons while price-sensitive financial information is being finalised and disclosed.

The company has also scheduled an earnings conference call for November 2, 2026, at 5:00 p.m. IST. Management is expected to discuss the Q2 FY27 performance with analysts and investors, who can participate using the dial-in details made available on the company’s website.

What did Neogen Chemicals Limited report in Q1 FY27?

Neogen Chemicals Limited reported stronger first-quarter performance for the period ended June 30, 2026, providing the immediate comparison point for the September-quarter announcement. Its Q1 FY27 earnings presentation showed revenue of Rs 252.3 crore, compared with Rs 184.6 crore in Q1 FY26, representing growth of 37%.

The same presentation reported EBITDA of Rs 48.2 crore, up 39% from Rs 34.7 crore a year earlier. EBITDA margin improved to 19.1% from 18.8%, a rise of 30 basis points. Profit after tax was Rs 17 crore, up 67% from Rs 10 crore in Q1 FY26.

Standalone quarterly data also showed net sales turnover of Rs 250.29 crore for the June 2026 quarter, compared with Rs 246.56 crore in the March 2026 quarter and Rs 186.73 crore in the June 2025 quarter. Standalone profit for the period was Rs 16.91 crore, versus Rs 11.36 crore in the preceding quarter and Rs 10.21 crore a year earlier.

How did the Dahej disruption and Neogen Ionics affect performance?

Neogen Chemicals Limited said its Q1 FY27 growth was achieved despite a temporary shutdown at its Dahej plant following a fire incident. The company said it managed the disruption through toll manufacturing sites, while higher volumes in key product lines supported revenue expansion.

The company also identified stronger throughput in its organolithium portfolio as a contributor to quarterly performance. It said favourable product mix helped it achieve its highest-ever quarterly revenues in both organolithium and battery-related products. Cost pass-throughs for raw materials and other inputs, including freight, packaging and utilities, were initiated to protect operating margins amid global headwinds.

Neogen Ionics, the company’s battery-chemicals joint venture, reported Q1 FY27 revenue of Rs 19 crore, compared with Rs 5 crore in the corresponding quarter of the prior year. The ramp-up of this business is relevant for investors because it contributed to the company’s consolidated growth while the Dahej facility’s operations were being restored.

The September 2026 quarter will also be compared with a weaker year-earlier base. Revenue for Q2 FY26 was reported at Rs 208.66 crore and profit after tax at Rs 3.28 crore in the quarterly data. Separate reporting on the prior-year quarter also cited revenue of Rs 206.68 crore and profit after tax of Rs 9.31 crore, reflecting the distinction between reported financial measures and formats in available disclosures.

What will investors watch in Neogen Chemicals Limited’s Q2 FY27 update?

Investors will look for the pace of revenue growth, margins and the operational status of the Dahej plant in Neogen Chemicals Limited’s Q2 FY27 disclosures. Q1 demonstrated that toll manufacturing and volume growth helped offset the effect of the temporary shutdown, but the company’s results and conference call will provide the formal update for the September quarter.

The battery-chemicals business will be another focal point after Neogen Ionics recorded Rs 19 crore of revenue in Q1 FY27. The company has also referred to an approved Rs 600 crore fundraise in connection with its growth plans, while previously stating FY27 standalone revenue guidance of Rs 875 crore to Rs 950 crore.

Earlier financial reporting also highlighted the financial consequences of the Dahej incident. Neogen Chemicals Limited reported receiving Rs 80.92 crore from insurance claims related to the fire. In Q2 FY26, it also received exchange fines totalling Rs 1,69,920 for non-compliance with SEBI regulations, while later issuing a corrigendum to rectify typographical errors in certain financial ratios in its Q2 and H1 FY26 results.

Conclusion

The October 31 board meeting is the next confirmed earnings event for Neogen Chemicals Limited after a first quarter marked by higher revenue, improved operating margin and growth in Neogen Ionics revenue. The Q2 results will show how the company performed through the September quarter as it managed the effects of the Dahej disruption and expanded key product lines.

The immediate scheduled milestone after the results is the November 2 earnings call, when management is expected to address analysts and investors. Market participants will watch for updates on Dahej operations, battery-chemicals revenue, margins, the Rs 875 crore to Rs 950 crore standalone revenue guidance and the approved Rs 600 crore fundraise.